News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
December, 2023
December 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Michelle Mitchell on The Francis Crick Institute Cut + Paste exhibition
Photo taken from Michelle Mitchell OBE/Linkedin
Oct 15, 2023, 17:22

Michelle Mitchell on The Francis Crick Institute Cut + Paste exhibition

Michelle Mitchell shared the following on LinkedIn:

“It was wonderful to come together with some of our partners, supporters, and ambassadors, at The Francis Crick Institute Cut + Paste exhibition last night. Our vision of creating a world where everybody lives, longer, better lives, free from the fear of cancer wouldn’t be possible without their support and we’re extremely grateful. Together we are beating cancer.

We were also lucky to be joined by our fantastic speakers, Dr Gillian Farnie, Group Leader of the Cancer Research Horizons Team at The Crick who shared the drug discovery research Cancer Research UK (CRUK) funds, and one of our media volunteers, Mei-Ling who shared her personal experience of cancer.”

For more information click here.
Source: Michelle Mitchell/LinkedIn

Michelle Mitchell is the first female chief executive of Cancer Research UK (CRUK), the world’s leading charitable funder of cancer research. In 2021/22 the charity had an income of £668m, spent £443m on cancer research and had approximately 4,000 staff and over 30,000 volunteers. Before joining Cancer Research UK, Michelle was CEO of the MS Society for five years and a founding member of the Progressive MS Alliance: a global scientific and research joint venture and launched the STOP MS £100m appeal. Prior to that, she was Director General at Age UK, the UK’s largest older people’s charity where she worked for nearly a decade and was at the forefront of national debates on health, care and welfare. Mitchell was appointed Order of the British Empire (OBE) in the 2016 New Year Honours for services to Older People and the Voluntary Sector. She was named by Cranfield University as one of the 100 Women to Watch in 2018.

cancer Cancer research Gillian Farnie Mei-Ling Michelle Mitchell OncoDaily Oncology The Francis Crick Institute
Blog
Dec 10, 2023, 20:01
Brittany Knick Ragon: If you are searching for a mentor, be sure to find one who brings light to those around them
Blog
Dec 10, 2023, 19:52
We spoke with Nerses Ghahramanyan on challenges that remain in the diagnosis and treatment of BPDCN - The Video Journal of Hematological Oncology
Opinion
Dec 10, 2023, 19:44
Valsamo Anagnostou: Here's the latest from the Johns Hopkins Kimmel Cancer Center Molecular Tumor Board
Blog
Dec 10, 2023, 19:32
Tomain Murphy: We celebrated a colossal milestone with the delivery of the proton accelerator
Blog
Dec 10, 2023, 19:19
Wafik S. El-Deiry: I am super excited to be able to share guest editorial in The Cancer Letter with the vision for the Worldwide Innovative Network WIN Consortium in cancer personalized medicine
Blog
Dec 10, 2023, 19:10
Margaret Foti: We are proud to work with our partners to help this critical symposium grow and thrive
Blog
Dec 10, 2023, 18:16
Jérôme Salomon: World Health Organization is also releasing a technical manual on alcohol tax policy and administration
Insight
Dec 10, 2023, 18:12
The Cancer Research Interns (CRI) Summer Program is now accepting applications! - Train at NCI
Insight
Dec 10, 2023, 18:08
Apply for the Basic Research in Cancer Health Disparities Program - NCI Center to Reduce Cancer Health Disparities (CRCHD)
Blog
Dec 10, 2023, 18:07
Nathan Vardi: I traveled down to Maryland and spent the day at the FDA
Insight
Dec 10, 2023, 18:01
Giselle Sholler: Our research that led to the FDA-Oncologic Drugs Advisory Committee 70% approval for moving Difluoromethylornithine forward
Blog
Dec 10, 2023, 17:54
Christian Rutzer: Roche and Novartis - Basel's Research and Innovation Powerhouses
Insight
Positive
Societies
Career